This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Scripps Research Institute. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Thomas F. Rogers: Innovator in Coronavirus Treatment
Introduction
Thomas F. Rogers is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral infections.
Latest Patents
Rogers holds a patent for "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are identified as potent inhibitors of the main protease (M) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). They are designed to be useful in treating or preventing COVID-19 in a subject.
Career Highlights
Rogers is affiliated with The Scripps Research Institute, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the fight against coronavirus infections.
Collaborations
Some of his notable coworkers include Arnab Kumar Chatterjee and Jian Jeffrey Chen. Their collaborative efforts contribute to the advancement of research in the field of virology and therapeutic development.
Conclusion
Thomas F. Rogers exemplifies the spirit of innovation in the pharmaceutical industry, particularly in addressing the challenges posed by viral infections such as COVID-19. His work continues to have a significant impact on public health.